Acorda Gets FDA Marketing Approval For Ampyra (Fampridine)

Sharon · Post by **Sharon** » Sat Jan 23, 2010 1:30 pm

Yesterday, the FDA approved the marketing of the drug Fampridine - it will now be marketed under the name Ampyra
http://www.rttnews.com/ArticleView.aspx ... 839&SMap=1

Sharon

Frank · Post by **Frank** » Sat Jan 23, 2010 1:50 pm

Is it already known what the sales price at pharmacies is going to be?

--Frank

Sharon · Post by **Sharon** » Sat Jan 23, 2010 2:39 pm

Frank -

Here is another link about the drug
<shortened url>

-- under the questions and answers section is information about cost

Q. What will Ampyra cost?

A. At the present time, no information has been released about how much Ampyra therapy will cost. The company expects to release that information in coming weeks.

Sharon

KateCW · Post by **KateCW** » Sat Jan 23, 2010 10:42 pm

A nurse at my MS clinic here in Calgary, Alberta (Canada) spoke to one of the nurses involved in some of the clinical trials. She said the cost will be "astronomical" about $20,000 per year, and it is doubtful if our drug coverage program will cover it. In Canada we can expect to wait several months or a year for it to be approved once it is approved in the USA.

This is my first post here, I'll have to do an introduction at some point!

Sharon · Post by **Sharon** » Sun Jan 24, 2010 7:58 am

$20,000 a year - oh, my gosh! And to think people have been getting this drug at compounding pharmacies for years (4-AP) at a nominal $$. There is something not in balance here!! I know, Acorda needs to get paid back for the research expense -- but, $20,000 per year?? I wonder if the US insurance companies will pay for it --

Sharon

Bear2 · Post by **Bear2** » Sun Jan 24, 2010 2:13 pm

Acorda has not priced this yet, they say by March. During many of their presentations at investor conf, they have indicated 5-10K but would dance around the answer when asked.

I exspect it to be some outrageous anount.

Jim

LisaE · Post by **LisaE** » Fri Jan 29, 2010 12:43 pm

I wanted to share an article I wrote on Ampyra/4-aminopyridine which pulls together history of the research and patient stories. I don't know of any other place on the web which has all of this information in one place.

It would be great if folks interested would come read and comment. Obviously I don't participate much here at all, but I do occasionally come to TIMS to catch up on the latest.

Article can be found at AMPYRA™ (dalfampridine) FDA-approved for MS patients; Connie and Melissa share their stories
or http://www.healthcentral.com/multiple-s ... 100/ampyra

BTW, I am the MS blogger at http://brassandivory.blogspot.com/